Suicide gene therapy with Herpes simplex virus thymidine kinase and ganciclovir is enhanced with connexins to improve gap junctions and bystander effects

被引:0
|
作者
Nicholas, TW
Read, SB
Burrows, FJ
Kruse, CA
机构
[1] Univ Colorado, Hlth Sci Ctr, Sch Med, Dept Immunol, Denver, CO 80262 USA
[2] Univ Colorado, Hlth Sci Ctr, Dept Pathol, Denver, CO 80262 USA
[3] Chiron Technol Ctr Gene Therapy, San Diego, CA USA
关键词
glioma; connexin; gap junctions; suicide gene therapy; bystander effect;
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Connexins are proteins that form gap junctions between cells in various mammalian tissues. Because of their role in intercellular communication, connexins are important in the bystander cell death seen in Herpes simplex virus-thymidine kinase (HSV-TK) gene therapy for brain tumors. A selective review of connexin transduction/transfection studies with particular emphasis to central nervous system tumor cells is presented. In addition, specific references to studies with cell types that demonstrate low gap junction intercellular communication are presented. Data are included with the HT-29 colorectal tumor cell line to support the concept that enhancing gap junction protein expression in otherwise low gap junction communicating HT-29 cells increases bystander cell death and reduces tumor burden beyond what might be expected from HSV-TK and ganciclovir (GCV) treatment alone. Maximum in vitro bystander cell death was always produced when GCV treated co-cultures of TK-transduced and non-TK-transduced HT-29 cell lines were also transduced with connexin-43. When connexin was present in only one group of cells in the co-culture, there was more bystander cell death observed with connexin transduced into the non- TK-transduced cells, rather than the TK-transduced cells. The data presented reinforces conclusions made from earlier findings from cell line mixing experiments in which the non-TK-transduced cell population determined the level of bystander cell death (Burrows et al., 2002).
引用
收藏
页码:495 / 507
页数:13
相关论文
共 50 条
  • [41] Potentiation of ganciclovir toxicity in the herpes simplex virus thymidine kinase/ganciclovir administration system by ponicidin
    Hayashi, K
    Hayashi, T
    Sun, HD
    Takeda, Y
    CANCER GENE THERAPY, 2000, 7 (01) : 45 - 52
  • [42] Mechanisms underlying the bystander killing effect of experimental glioma cells in herpes simplex virus thymidine kinase ganciclovir system
    Du, LP
    Bai, SC
    Whittle, IR
    He, L
    CANCER GENE THERAPY, 1997, 4 (05) : 305 - 305
  • [43] Elimination of the truncated message from the herpes simplex virus thymidine kinase suicide gene
    Chalmers, D
    Ferrand, C
    Apperley, JF
    Melo, JV
    Ebeling, S
    Newton, I
    Duperrier, A
    Hagenbeek, A
    Garrett, E
    Tiberghien, P
    Garin, M
    MOLECULAR THERAPY, 2001, 4 (02) : 146 - 148
  • [44] Potentiation of ganciclovir toxicity in the herpes simplex virus thymidine kinase/ganciclovir administration system by ponicidin
    Kyoko Hayashi
    Toshimitsu Hayashi
    Han-Dong Sun
    Yoshio Takeda
    Cancer Gene Therapy, 2000, 7 : 45 - 52
  • [45] Human prostate carcinoma cells as targets for herpes simplex virus thymidine kinase–mediated suicide gene therapy
    Sami Loimas
    Marjo-Riitta Toppinen
    Tapio Visakorpi
    Juhani Jänne
    Jarmo Wahlfors
    Cancer Gene Therapy, 2001, 8 : 137 - 144
  • [46] Herpes simplex virus thymidine kinase-mediated suicide gene therapy using nano/microbubbles and ultrasound
    Aoi, Atsuko
    Watanabe, Yukiko
    Mori, Shiro
    Takahashi, Masahiko
    Vassaux, Georges
    Kodama, Tetsuya
    ULTRASOUND IN MEDICINE AND BIOLOGY, 2008, 34 (03): : 425 - 434
  • [47] Herpes simplex virus thymidine kinase/ganciclovir system in multicellular tumor spheroids
    Liliana ME Finocchiaro
    Viviana F Bumaschny
    Armando L Karara
    Gabriel L Fiszman
    Cecilia C Casais
    Gerardo C Glikin
    Cancer Gene Therapy, 2004, 11 : 333 - 345
  • [48] Herpes simplex virus thymidine kinase/ganciclovir system in multicellular tumor spheroids
    Finocchiaro, LME
    Bumaschny, VF
    Karara, AL
    Fiszman, GL
    Casais, CC
    Glikin, GC
    CANCER GENE THERAPY, 2004, 11 (05) : 333 - 345
  • [49] Tomato thymidine kinase-based suicide gene therapy for malignant glioma—an alternative for Herpes Simplex virus-1 thymidine kinase
    H Stedt
    H Samaranayake
    J Kurkipuro
    G Wirth
    L S Christiansen
    T Vuorio
    A-M Määttä
    J Piškur
    S Ylä-Herttuala
    Cancer Gene Therapy, 2015, 22 : 130 - 137
  • [50] A cell type-specific and gap junction-independent mechanism for the herpes simplex virus-1 Thymidine kinase gene/ganciclovir-mediated bystander effect
    Princen, F
    Robe, P
    Lechanteur, C
    Mesnil, M
    Rigo, JM
    Gielen, J
    Merville, MP
    Bours, V
    CLINICAL CANCER RESEARCH, 1999, 5 (11) : 3639 - 3644